Monoclonal antibodies for therapy, prevention and in vivo diagnosis of human disease, Utrecht, The Netherlands, May 17-19, 1989Developments in biological standardization. 1990, Vol 71, issn 0301-5149, 261 p.Conference Proceedings

Proceedings/19th IABS congress on use and standardization of combined vaccines, Amsterdam, NLD, 10-13 December, 1985Developments in biological standardization. 1986, Vol 65, issn 0301-5149, 284 p.Conference Proceedings

Proceedings/Fourth international symposium on Pertussis, Geneva, CHE, 25.-27. Sept. 1984Developments in biological standardization. 1985, Vol 61, issn 0301-5149, XII-594 pConference Proceedings

Standardization of the immunopharmacology of natural and synthetic immunomodulators. International symposiumDevelopments in biological standardization. 1992, Num 77, issn 0301-5149, 258 p.Conference Proceedings

ProceedingsüJoint IABS-CSL symposium on standardization in blood fractionation including Coagulation factors, Melbourne 7-9 May 1986Developments in biological standardization. 1987, Vol 67, issn 0301-5149, 382 p.Conference Proceedings

Proceedings/Symposium on diagnostics and vaccines for parasitic diseases, Stockholm, Sweden, 20-22 February, 1985Developments in biological standardization. 1985, Vol 62, issn 0301-5149, VIII-158 pConference Proceedings

INTERNATIONAL SYMPOSIUM ON FISH BIOLOGICS: SERODIAGNOSTICS AND VACCINES. PROCEEDINGS OF A SYMPOSIUM ORGANIZED BY THE INTERNATIONAL ASSOCIATION OF BIOLOGICAL STANDARDIZATION AND HELD AT THE NATIONAL FISH HEALTH RESEARCH LABORATION, LEETOWN, W.VA., U.S.A., APRIL 26-30, 19811981; DEV. BIOL. STAND.; ISSN 0301-5149; CHE; DA. 1981; VOL. 49; 489 P.; BIBL. DISSEM.Conference Paper

Transmissible spongiform encephalopathies : impact on animal and human health. MeetingDevelopments in biological standardization. 1993, Num 80, issn 0301-5149Conference Proceedings

Proceedings/Third International Symposium on Brucellosis by the International Association of Biological Standardization, Algiers, April 18-20, 1983Developments in biological standardization. 1984, Vol 56, issn 0301-5149, XIII p.-779 pConference Proceedings

Viral hepatitis: standardization in immunoprophylaxis of infections by hepatitis viruses. Proceedings of the second WHO/IABS symposium, held at the Caravel Hotel, Athens, Greece, November 15-18, 1982Developments in biological standardization. 1983, Vol 54, issn 0301-5149, XVIII-585 pConference Proceedings

INTERNATIONAL SYMPOSIUM ON REASSESSMENT OF INACTIVED POLIOMYELITIS VACCINEHUYGELEN C PREF.1981; DEV. BIOL. STAND.; ISSN 0301-5149; CHE; DA. 1981; VOL. 47; 372 P.; BIBL. DISSEM.Conference Paper

STANDARDIZATION OF ALBUMIN, PLASMA SUBSTITUTES AND PLASMAPHERESIS. PROCEEDINGS OF A SYMPOSIUM ORGANIZED BY THE INTERNATIONAL ASSOCIATION OF BIOLOGICAL STANDARDIZATION AND HELD AT THE WORLD HEALTH ORGANIZATION GENEVA, SWITZERLAND NOVEMBER 10-12, 19801981; DEV. BIOL. STAND.; ISSN 0301-5149; CHE; DA. 1981; VOL. 48; 333 P.; BIBL. DISSEM.Conference Paper

Factors affecting the stability of viral vaccinesPEETERMANS, J.Developments in biological standardization. 1996, Num 87, pp 97-101, issn 0301-5149Conference Paper

Immunotoxicology of immunmodulatorsDESCOTES, J.Developments in biological standardization. 1992, Num 77, pp 99-102, issn 0301-5149Conference Paper

20th IABS congress on cytokines: laboratory and clinical evaluation, London, GBR, 19-21 October, 1987Developments in biological standardization. 1988, Vol 69, issn 0301-5149, XI-235 p. [245 p.]Conference Proceedings

New approaches to stabilisation of vaccines potencyBROWN, Fred.Developments in biological standardization. 1996, Num 87, issn 0301-5149, 367 p.Conference Proceedings

Stability testing requirements for vaccines : Draft guidelines of the International on HarmonizationHAASE, M.Developments in biological standardization. 1996, Num 87, pp 309-318, issn 0301-5149Conference Paper

Classification of immunotherapeutic agentsHADDEN, J. W.Developments in biological standardization. 1992, Num 77, pp 5-15, issn 0301-5149Conference Paper

How can we stimulate the immune system in vivo ?ZINKERNAGEL, R. M.Developments in biological standardization. 1992, Num 77, pp 29-30, issn 0301-5149Conference Paper

Recent progress in immunopharmacology and therapeutic effects of polysaccharidesCHIHARA, G.Developments in biological standardization. 1992, Num 77, pp 191-197, issn 0301-5149Conference Paper

Standardized viability test required for preventive, immunomodulator and recombinant BCG vaccineLUGOSI, L.Developments in biological standardization. 1992, Num 77, pp 211-215, issn 0301-5149Conference Paper

Synthetic lipopeptide immunomodulators derived from bacterial lipoprotein : tools for the standardization of in vitro assaysBESSLER, W. G.Developments in biological standardization. 1992, Num 77, pp 49-56, issn 0301-5149Conference Paper

Proceedings. Part B/BCG vaccines and tuberculins, symposium, Budapest, HUN, September 6-9, 1983Developments in biological standardization. 1986, Vol 58, pp 475-781, issn 0301-5149, BConference Proceedings

Regulatory practices and problems with vaccine stability studies and the establishment of shelf livesFENYVES, A.Developments in biological standardization. 1996, Num 87, pp 329-333, issn 0301-5149Conference Paper

Bovine spongiform encephalopathy and its association with the feeding of ruminant-derived proteinTAYLOR, D. M.Developments in biological standardization. 1993, Num 80, pp 215-224, issn 0301-5149Conference Paper